Related Experiment Video
Updated: May 21, 2026
04:47
Du-Moxibustion in a Mouse Model of Ankylosing Spondylitis
Published on: October 27, 2023
NSAIDs: eNdocannabinoid stimulating anti-inflammatory drugs?
1Department of Pharmacology and Clinical Neuroscience, Umeå University, SE-901 87 Umeå, Sweden.
Trends in Pharmacological Sciences
|June 6, 2012
Summary
Nonsteroidal anti-inflammatory drugs (NSAIDs) primarily inhibit cyclooxygenase (COX), but emerging evidence suggests they also interact with the endocannabinoid system. This interaction may lead to developing safer pain relievers with fewer side effects.
Area of Science:
- Pharmacology
- Neuroscience
- Drug Development
Background:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely understood to exert their effects by inhibiting cyclooxygenase (COX) enzymes and reducing prostaglandin synthesis.
- Accumulating evidence indicates a significant involvement of the endocannabinoid system in the mechanisms of action of NSAIDs.
- This interaction presents a potential avenue for developing novel analgesic therapies.
Purpose of the Study:
- To review the current understanding of the endocannabinoid system's role in NSAID activity.
- To discuss how this understanding can inform the development of new pain relief medications.
- To explore strategies for creating analgesics with improved safety profiles.
Main Methods:
- Literature review and synthesis of existing research on NSAIDs and the endocannabinoid system.
- Analysis of pharmacological data and proposed mechanisms of action.
- Discussion of potential therapeutic targets and drug design strategies.
Main Results:
- NSAIDs engage with the endocannabinoid system, suggesting a broader mechanism of action beyond COX inhibition.
- This engagement offers a potential explanation for some of the therapeutic and adverse effects of NSAIDs.
- Understanding this interplay is crucial for advancing analgesic drug discovery.
Conclusions:
- The endocannabinoid system is an integral component of NSAID pharmacology.
- Targeting the endocannabinoid system in conjunction with COX inhibition could yield safer and more effective analgesics.
- Future research should focus on elucidating these interactions to optimize pain management strategies.
Related Concept Videos
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
01:44Nociception
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain. Thus, pain helps the...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.